252 related articles for article (PubMed ID: 35045281)
21. A pharmacological chaperone improves memory by reducing Aβ and tau neuropathology in a mouse model with plaques and tangles.
Li JG; Chiu J; Ramanjulu M; Blass BE; Praticò D
Mol Neurodegener; 2020 Jan; 15(1):1. PubMed ID: 31964406
[TBL] [Abstract][Full Text] [Related]
22. The Retromer Supports AMPA Receptor Trafficking During LTP.
Temkin P; Morishita W; Goswami D; Arendt K; Chen L; Malenka R
Neuron; 2017 Apr; 94(1):74-82.e5. PubMed ID: 28384478
[TBL] [Abstract][Full Text] [Related]
23. Formation of retromer transport carriers is disrupted by the Parkinson disease-linked Vps35 D620N variant.
Cui Y; Yang Z; Flores-Rodriguez N; Follett J; Ariotti N; Wall AA; Parton RG; Teasdale RD
Traffic; 2021 Apr; 22(4):123-136. PubMed ID: 33347683
[TBL] [Abstract][Full Text] [Related]
24. Hyperleucinemia causes hippocampal retromer deficiency linking diabetes to Alzheimer's disease.
Morabito MV; Berman DE; Schneider RT; Zhang Y; Leibel RL; Small SA
Neurobiol Dis; 2014 May; 65():188-92. PubMed ID: 24440570
[TBL] [Abstract][Full Text] [Related]
25. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
26. The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders.
Berman DE; Ringe D; Petsko GA; Small SA
Neurotherapeutics; 2015 Jan; 12(1):12-8. PubMed ID: 25472693
[TBL] [Abstract][Full Text] [Related]
27. Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease.
Lucin KM; O'Brien CE; Bieri G; Czirr E; Mosher KI; Abbey RJ; Mastroeni DF; Rogers J; Spencer B; Masliah E; Wyss-Coray T
Neuron; 2013 Sep; 79(5):873-86. PubMed ID: 24012002
[TBL] [Abstract][Full Text] [Related]
28. VPS35 depletion does not impair presynaptic structure and function.
Vazquez-Sanchez S; Bobeldijk S; Dekker MP; van Keimpema L; van Weering JRT
Sci Rep; 2018 Feb; 8(1):2996. PubMed ID: 29445238
[TBL] [Abstract][Full Text] [Related]
29. Microglial VPS35 deficiency regulates microglial polarization and decreases ischemic stroke-induced damage in the cortex.
Ye SY; Apple JE; Ren X; Tang FL; Yao LL; Wang YG; Mei L; Zhou YG; Xiong WC
J Neuroinflammation; 2019 Nov; 16(1):235. PubMed ID: 31771656
[TBL] [Abstract][Full Text] [Related]
30. VPS35 regulates tau phosphorylation and neuropathology in tauopathy.
Vagnozzi AN; Li JG; Chiu J; Razmpour R; Warfield R; Ramirez SH; Praticò D
Mol Psychiatry; 2021 Nov; 26(11):6992-7005. PubMed ID: 31289348
[TBL] [Abstract][Full Text] [Related]
31. Beneficial Effect of a Small Pharmacologic Chaperone on the Established Alzheimer's Disease Phenotype.
Li JG; Blass BE; Praticò D
J Alzheimers Dis; 2023; 91(1):463-469. PubMed ID: 36442197
[TBL] [Abstract][Full Text] [Related]
32. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
33. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
[TBL] [Abstract][Full Text] [Related]
34. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
35. Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson's disease VPS35 mutation p.D620N.
Munsie LN; Milnerwood AJ; Seibler P; Beccano-Kelly DA; Tatarnikov I; Khinda J; Volta M; Kadgien C; Cao LP; Tapia L; Klein C; Farrer MJ
Hum Mol Genet; 2015 Mar; 24(6):1691-703. PubMed ID: 25416282
[TBL] [Abstract][Full Text] [Related]
36. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.
Lane RF; Raines SM; Steele JW; Ehrlich ME; Lah JA; Small SA; Tanzi RE; Attie AD; Gandy S
J Neurosci; 2010 Sep; 30(39):13110-5. PubMed ID: 20881129
[TBL] [Abstract][Full Text] [Related]
37. Cargo trafficking in Alzheimer’s disease: the possible role of retromer.
Sadigh-Eteghad S; Askari-Nejad MS; Mahmoudi J; Majdi A
Neurol Sci; 2016 Jan; 37(1):17-22. PubMed ID: 26482054
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
[TBL] [Abstract][Full Text] [Related]
39. The retromer complex system in a transgenic mouse model of AD: influence of age.
Chu J; Praticò D
Neurobiol Aging; 2017 Apr; 52():32-38. PubMed ID: 28110103
[TBL] [Abstract][Full Text] [Related]
40. Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking.
Kim E; Lee Y; Lee HJ; Kim JS; Song BS; Huh JW; Lee SR; Kim SU; Kim SH; Hong Y; Shim I; Chang KT
Biochem Biophys Res Commun; 2010 Dec; 403(2):167-71. PubMed ID: 21040701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
